WASHINGTON (AP) — Democrats are committed to passing legislation this year to curb prescription drug prices, but they're still disagreeing on how to cut costs for patients and taxpayers while preserving profits that lure investors to back potentially promising treatments.
CHICAGO — Illinois is lifting all capacity limits on bars, restaurants, businesses and other venues Friday, nearly 15 months after the first stay-at-home order during the coronavirus pandemic.
WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.
A new Alzheimer's drug would raise Medicare premiums broadly, and some patients could face copayments of about $11,500 annually, a report says.
WASHINGTON (AP) — The rich really are different from you and me: They’re better at dodging the tax collector.
Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment.
The FDA on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers.
Chiquita Brooks-LaSure, the new head of the Centers for Medicare & Medicaid Services, said the administration will focus on getting more people insured and is interested in finding a way to alleviate the gap keeping low-income families in states that haven’t expanded Medicaid from enrolling in Affordable Care Act health plans.
How proposed changes to Medicare could impact you.
Lawmakers are working on fleshing out the concept of a “public option,” a government-run or heavily regulated insurance plan that would compete with private insurance. But the details are complicated, both substantively and politically. Meanwhile, bioethicists are debating whether the U.S. should be vaccinating low-risk adolescents against covid-19 while high-risk adults in other countries are still waiting. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
WASHINGTON (AP) — Two leading congressional Democrats issued a call Wednesday for ideas on a “public option” health insurance plan, a campaign promise of President Joe Biden's that faces long odds politically.
WASHINGTON (AP) — The Justice Department announced criminal charges Wednesday against more than a dozen people from Florida to California in a series of Medicare scams that exploited coronavirus fears to bill tens of millions of dollars in bogus claims.
WASHINGTON (AP) — The Senate on Tuesday confirmed President Joe Biden’s pick to run U.S. health insurance programs, putting in place a key player who’ll carry out his strategy for expanding affordable coverage and reining in prescription drug costs.
If you’re 65 or older, still working and are covered by employer health insurance, it can make sense to sign up for Medicare now. Enrollment might reduce your out-of-pocket costs.…
WASHINGTON (AP) — President Joe Biden and progressive Democrats have proposed to lower Medicare’s eligibility age to 60, to help older adults get affordable coverage. But a new study finds that Medicare can be more expensive than other options, particularly for many people of modest means.
Slightly more than half of U.S. adults (53%) support expanding Medicare benefits to include hearing, dental and vision care, according to a new NerdWallet survey. And 54% support the government…
More than 44 million Americans 65 and older have gotten at least one dose of the COVID-19 vaccine, and over 36 million are fully vaccinated, according to recent data from…
WASHINGTON — President Joe Biden is proposing a major expansion of the government's role in long-term care, but questions are being raised over his using the low-income Medicaid program and piggybacking the whole idea on an infrastructure bill.
The $1.9 trillion covid relief bill expands subsidies for private insurance plans. That will lighten the burden on consumers, but it locks taxpayers into yet more support for the health care industry.